Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma
- PMID: 18986314
- DOI: 10.1111/j.1532-950X.2008.00409.x
Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma
Abstract
Objective: To investigate the histologic characteristics of feline osteosarcoma (OS) and compare the histologic data with phenotypically comparable canine OS. The effects of histologic and clinical variables on survival statistics were evaluated.
Study design: Retrospective study.
Animals: Cats (n=62) and dogs (22).
Methods: Medical records of 62 cats with OS were reviewed for clinically relevant data. Clinical outcome was obtained by telephone interview. Histologic characteristics of OS were classified using a standardized grading system. Histologic characteristics in 22 feline skeletal OS were compared with 22 canine skeletal OS of identical location and subtype. Prognostic variables for clinical outcome were determined using multivariate analysis.
Results: Feline OS was characterized by moderate to abundant cellular pleomorphism, low mitotic index, small to moderate amounts of matrix, high cellularity, and a moderate amount of necrosis. There was no significant difference between histologic variables in feline and canine OS. Histologic grade, surgery, and mitotic index significantly influenced clinical outcome as determined by multivariate analysis. Tumor invasion into vessels was not identified as a significant prognosticator.
Conclusion: Feline and canine skeletal OS have similar histologic but different prognostic characteristics.
Clinical relevance: Prognosis for cats with OS is related to histologic grade and mitotic index of the tumor.
Similar articles
-
TP53 gene mutations in canine osteosarcoma.Vet Surg. 2008 Jul;37(5):454-60. doi: 10.1111/j.1532-950X.2008.00407.x. Vet Surg. 2008. PMID: 18986312
-
Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.Vet Pathol. 2013 Jul;50(4):704-8. doi: 10.1177/0300985812471542. Epub 2012 Dec 26. Vet Pathol. 2013. PMID: 23269349
-
Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).J Am Vet Med Assoc. 2006 Jun 15;228(12):1905-8. doi: 10.2460/javma.228.12.1905. J Am Vet Med Assoc. 2006. PMID: 16784383
-
Common malignant musculoskeletal neoplasms of dogs and cats.Vet Clin North Am Small Anim Pract. 2005 Sep;35(5):1155-67, vi. doi: 10.1016/j.cvsm.2005.05.004. Vet Clin North Am Small Anim Pract. 2005. PMID: 16129137 Review.
-
Surgery for skeletal sarcomas.Clin Tech Small Anim Pract. 1998 Feb;13(1):53-8. doi: 10.1016/S1096-2867(98)80028-5. Clin Tech Small Anim Pract. 1998. PMID: 9634349 Review.
Cited by
-
Companion Animals as Models for Inhibition of STAT3 and STAT5.Cancers (Basel). 2019 Dec 17;11(12):2035. doi: 10.3390/cancers11122035. Cancers (Basel). 2019. PMID: 31861073 Free PMC article. Review.
-
Fracture-associated osteosarcoma of the femur in a cat.Can Vet J. 2018 Oct;59(10):1096-1098. Can Vet J. 2018. PMID: 30510315 Free PMC article.
-
Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.Can J Vet Res. 2016 Jan;80(1):66-73. Can J Vet Res. 2016. PMID: 26733734 Free PMC article.
-
Stem cell growth factor receptor in canine vs. feline osteosarcomas.Oncol Lett. 2016 Oct;12(4):2485-2492. doi: 10.3892/ol.2016.5006. Epub 2016 Aug 12. Oncol Lett. 2016. PMID: 27698817 Free PMC article.
-
Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in feline tumors.Vet Pathol. 2024 Sep;61(5):743-751. doi: 10.1177/03009858241239566. Epub 2024 Mar 27. Vet Pathol. 2024. PMID: 38533803 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous